What’s on the Horizon for Chronic Lymphocytic Leukemia?
May 8, 2018
Topics Covered
We invite you to learn more about:
- Diagnosing chronic lymphocytic leukemia (CLL)
- New and emerging therapies
- Supportive care and side-effects management
- The importance of shared decision making when discussing treatment
Speaker
Matthew S. Davids, MD, MMSc
Associate Director
Center for Chronic Lymphocytic Leukemia
Assistant Professor of Medicine
Harvard Medical School
Dana Farber Institute
Boston, MA
Audio Replay
Program Materials
Program Support
Support for this program provided by AbbVie; Genentech and Biogen; Pharmacyclics, an AbbVie Company and Janssen Biotech.